Carregant...
Expression of NY-ESO-1 in Primary and Metastatic Melanoma
NY-ESO-1, a cancer testis antigen, is an ideal target for adoptive cell transfer immunotherapy. Evidence from several clinical trials in melanoma and other malignancies shows the potential value of targeting the NY-ESO-1 antigen in immune-based therapy of metastatic tumors. However, the incidence of...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3946994/ https://ncbi.nlm.nih.gov/pubmed/24290058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.humpath.2013.05.029 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|